Twist Bioscience (TWST) Research & Development (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Research & Development data on file, last reported at $19.7 million in Q1 2026.

• Research & Development for Q1 2026 came in at $19.7 million, down 17.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.9 million (down 19.07% YoY), and the FY2025 annual result was $80.3 million, down 11.63% from the prior year.
• Research & Development advanced to $19.7 million in Q1 2026 per TWST's latest filing, from $17.1 million in the prior quarter.
• Over five years, Research & Development peaked at $36.8 million in Q2 2022 and troughed at $17.0 million in Q3 2025.
• A 5-year average of $24.3 million and a median of $23.7 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2023: Research & Development soared 97.78% in 2022, then plunged 33.42% in 2023.
• A 5-year view of Research & Development shows it stood at $31.2 million in 2022, then retreated by 26.06% to $23.1 million in 2023, then retreated by 7.76% to $21.3 million in 2024, then slipped by 19.6% to $17.1 million in 2025, then gained by 14.97% to $19.7 million in 2026.
• Business Quant data shows TWST's Research & Development at $19.7 million in Q1 2026, $17.1 million in Q4 2025, and $17.0 million in Q3 2025.